Tempest Therapeutics, Inc. (TPST)

NASDAQ: TPST · IEX Real-Time Price · USD

2.120

-0.020 (-0.93%)

At close: Jul 2, 2024, 4:00 PM

2.090

-0.030 (-1.42%)

After-hours: Jul 2, 2024, 7:59 PM EDT

Tempest Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2012
Selling, General & Admin	11.66	12.11	9.82	4.91	17.56	Upgrade
Research & Development	17.5	22.53	17.17	14.39	27.84	Upgrade
Other Operating Expenses	0	0	0	0	0.21	Upgrade
Operating Expenses	29.16	34.64	26.99	19.3	45.61	Upgrade
Operating Income	-29.16	-34.64	-26.99	-19.3	-45.61	Upgrade
Interest Expense / Income	1.45	1.62	1.28	-0.09	0	Upgrade
Other Expense / Income	-1.12	-0.55	0.03	-	-1.04	Upgrade
Pretax Income	-29.49	-35.71	-28.3	-19.21	-44.57	Upgrade
Net Income	-29.49	-35.71	-28.3	-19.21	-44.57	Upgrade
Shares Outstanding (Basic)	15	12	4	0	1	Upgrade
Shares Outstanding (Diluted)	15	12	4	0	1	Upgrade
Shares Change	33.49%	204.70%	709.62%	-48.77%	785.99%	Upgrade
EPS (Basic)	-1.91	-3.09	-7.47	-41.03	-48.75	Upgrade
EPS (Diluted)	-1.91	-3.09	-7.47	-41.03	-48.75	Upgrade
Free Cash Flow	-27.53	-31.63	-26.09	-19.07	-41.62	Upgrade
Free Cash Flow Per Share	-1.79	-2.74	-6.88	-40.73	-45.55	Upgrade
EBITDA	-25.96	-32.28	-25.75	-18.48	-43.52	Upgrade
Depreciation & Amortization	2.08	1.81	1.27	0.82	1.05	Upgrade
EBIT	-28.04	-34.09	-27.02	-19.3	-44.57	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).